Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 408

1.

Wnt signaling in triple negative breast cancer is associated with metastasis.

Dey N, Barwick BG, Moreno CS, Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C, Kerstann KF, Sledge GW Jr, Abramovitz M, Bouzyk M, De P, Leyland-Jones BR.

BMC Cancer. 2013 Nov 10;13:537. doi: 10.1186/1471-2407-13-537.

2.

Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.

De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N.

Oncotarget. 2016 Jul 12;7(28):43124-43149. doi: 10.18632/oncotarget.8988.

3.

Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.

Henry C, Quadir A, Hawkins NJ, Jary E, Llamosas E, Kumar D, Daniels B, Ward RL, Ford CE.

J Cancer Res Clin Oncol. 2015 Feb;141(2):243-54. doi: 10.1007/s00432-014-1824-y. Epub 2014 Sep 11.

PMID:
25209439
4.

RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.

De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.

Oncotarget. 2017 Jan 10;8(2):3072-3103. doi: 10.18632/oncotarget.13618.

5.

Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.

Dey N, Young B, Abramovitz M, Bouzyk M, Barwick B, De P, Leyland-Jones B.

PLoS One. 2013 Oct 15;8(10):e77425. doi: 10.1371/journal.pone.0077425. eCollection 2013.

6.
7.

β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.

Klemm F, Bleckmann A, Siam L, Chuang HN, Rietkötter E, Behme D, Schulz M, Schaffrinski M, Schindler S, Trümper L, Kramer F, Beissbarth T, Stadelmann C, Binder C, Pukrop T.

Carcinogenesis. 2011 Mar;32(3):434-42. doi: 10.1093/carcin/bgq269. Epub 2010 Dec 20.

PMID:
21173432
8.

Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.

Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, Li H.

Oncol Rep. 2017 Feb;37(2):895-902. doi: 10.3892/or.2016.5311. Epub 2016 Dec 12.

PMID:
27959422
9.

Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.

Yu L, Li X, Li H, Chen H, Liu H.

Tumour Biol. 2016 Oct;37(10):13821-13829. Epub 2016 Aug 1.

PMID:
27481517
10.

Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.

Johnson RW, Merkel AR, Page JM, Ruppender NS, Guelcher SA, Sterling JA.

Clin Exp Metastasis. 2014 Dec;31(8):945-59. doi: 10.1007/s10585-014-9682-1. Epub 2014 Oct 31.

11.

Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.

Bilir B, Kucuk O, Moreno CS.

J Transl Med. 2013 Nov 4;11:280. doi: 10.1186/1479-5876-11-280.

12.

Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.

Du Q, Zhang X, Liu Q, Zhang X, Bartels CE, Geller DA.

Cancer Res. 2013 Nov 1;73(21):6526-37. doi: 10.1158/0008-5472.CAN-13-1620. Epub 2013 Sep 5.

13.

RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.

Jiang Y, Sheng H, Meng L, Yue H, Li B, Zhang A, Dong Y, Liu Y.

World J Surg Oncol. 2017 Jan 6;15(1):9. doi: 10.1186/s12957-016-1084-1.

14.

c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.

Li Y, Jin K, van Pelt GW, van Dam H, Yu X, Mesker WE, Ten Dijke P, Zhou F, Zhang L.

Cancer Res. 2016 Jun 1;76(11):3364-75. doi: 10.1158/0008-5472.CAN-15-2302. Epub 2016 Apr 5.

15.

The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.

Tzeng HE, Yang L, Chen K, Wang Y, Liu YR, Pan SL, Gaur S, Hu S, Yen Y.

Oncotarget. 2015 May 10;6(13):11061-73.

16.

Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.

Wang R, Sun Q, Wang P, Liu M, Xiong S, Luo J, Huang H, Du Q, Geller DA, Cheng B.

Oncotarget. 2016 Feb 2;7(5):5754-68. doi: 10.18632/oncotarget.6805.

17.

ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.

Wu L, Zhao JC, Kim J, Jin HJ, Wang CY, Yu J.

Cancer Res. 2013 Oct 1;73(19):6068-79. doi: 10.1158/0008-5472.CAN-13-0882. Epub 2013 Aug 1.

18.

High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.

Zhu B, Cheng D, Li S, Zhou S, Yang Q.

Int J Mol Sci. 2016 Jul 22;17(7). pii: E1188. doi: 10.3390/ijms17071188.

19.

Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.

Meier-Abt F, Milani E, Roloff T, Brinkhaus H, Duss S, Meyer DS, Klebba I, Balwierz PJ, van Nimwegen E, Bentires-Alj M.

Breast Cancer Res. 2013 Apr 29;15(2):R36. doi: 10.1186/bcr3419.

20.

The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.

Fatima I, El-Ayachi I, Taotao L, Lillo MA, Krutilina R, Seagroves TN, Radaszkiewicz TW, Hutnan M, Bryja V, Krum SA, Rivas F, Miranda-Carboni GA.

PLoS One. 2017 Dec 27;12(12):e0189864. doi: 10.1371/journal.pone.0189864. eCollection 2017. Erratum in: PLoS One. 2018 May 17;13(5):e0197796.

Supplemental Content

Support Center